{
  "id": "R46954",
  "type": "CRS Report",
  "typeId": "R",
  "number": "R46954",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source": "CRSReports.Congress.gov",
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R46954",
      "id": "R46954_5_2022-02-16",
      "date": "2022-02-16",
      "retrieved": "2022-03-24T04:03:43.646907",
      "title": "COVID-19 and Access to Medical Products: Implications of Section 301 Tariffs",
      "summary": null,
      "type": "CRS Report",
      "typeId": "R",
      "active": true,
      "formats": [
        {
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R46954/5",
          "sha1": "9aed6b7dc2a670a4fba435720d81648cd4acd7af",
          "filename": "files/2022-02-16_R46954_9aed6b7dc2a670a4fba435720d81648cd4acd7af.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/2022-02-16_R46954_9aed6b7dc2a670a4fba435720d81648cd4acd7af.html",
          "source": "pymupdf"
        }
      ],
      "source_dir": "crsreports.congress.gov"
    },
    {
      "source": "CRSReports.Congress.gov",
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R46954",
      "id": "R46954_3_2021-11-17",
      "date": "2021-11-17",
      "retrieved": "2022-03-24T04:03:43.645576",
      "title": "COVID-19 and Access to Medical Products: Implications of Section 301 Tariffs",
      "summary": null,
      "type": "CRS Report",
      "typeId": "R",
      "active": true,
      "formats": [
        {
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R46954/3",
          "sha1": "7a5f73e6d3389863f7654f99c625c54c1f6316e5",
          "filename": "files/2021-11-17_R46954_7a5f73e6d3389863f7654f99c625c54c1f6316e5.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/2021-11-17_R46954_7a5f73e6d3389863f7654f99c625c54c1f6316e5.html",
          "source": "pymupdf"
        }
      ],
      "source_dir": "crsreports.congress.gov"
    },
    {
      "source": "CRSReports.Congress.gov",
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R46954",
      "id": "R46954_1_2021-11-03",
      "date": "2021-11-03",
      "retrieved": "2022-03-24T04:03:43.644277",
      "title": "COVID-19 and Access to Medical Products: Implications of Section 301 Tariffs",
      "summary": null,
      "type": "CRS Report",
      "typeId": "R",
      "active": true,
      "formats": [
        {
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R46954/1",
          "sha1": "904a56580042b1cd3c57633277c442144692d910",
          "filename": "files/2021-11-03_R46954_904a56580042b1cd3c57633277c442144692d910.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/2021-11-03_R46954_904a56580042b1cd3c57633277c442144692d910.html",
          "source": "pymupdf"
        }
      ],
      "source_dir": "crsreports.congress.gov"
    }
  ],
  "topics": [
    "Foreign Affairs",
    "Industry and Trade"
  ]
}